ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell Carcinoma (Rad/Sutent)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00788060
Recruitment Status : Completed
First Posted : November 10, 2008
Last Update Posted : February 16, 2015
Sponsor:
Collaborators:
Novartis
Pfizer
Information provided by (Responsible Party):
Daniel George, MD, Duke University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2012
  Actual Study Completion Date : December 2012